Where Medical
Innovation Meets
Intelligent Capital
MedVC.ai is the only platform that automates FDA diligence, sources deals with AI, and executes post-funding clinical growth — across the entire medical startup lifecycle.
Four Ways to Work
With MedVC.ai
We monetize every stage of the medical startup lifecycle — from discovery to funding to market entry.
Investor-Ready Sprint
30-day intensive that transforms your startup into a fully investor-ready entity. Includes a Complizen FDA roadmap, Yutori competitive analysis, and pitch deck refinement.
AI Deal Flow Engine
Custom Yutori Scouts deployed to your investment thesis. Every deal arrives pre-vetted with a Complizen regulatory risk score — no analyst hours required.
The MedVC Syndicate
Exclusive co-investment access for medical professionals. Invest alongside institutional VCs in AI-vetted medical startups — with the same diligence infrastructure they use.
Post-Funding Growth
You raised the capital. Now reach the doctors. The MedConnect 3-phase direct-mail framework achieves 87% open rates with clinical decision-makers — where digital ads fail.
One Platform.
Every Stage.
MedVC.ai is the only platform that monetizes every stage of a medical startup's lifecycle.
Yutori Scouts
AI agents discover your startup before you pitch
Complizen Diligence
Instant FDA pathway analysis de-risks the deal
MedVC Closes
Capital deployed through the Syndicate or VC network
MedConnect Grows
Direct-mail campaigns acquire first clinical customers
Yutori finds the startups → Complizen de-risks them → MedVC.ai closes the funding → MedConnect drives clinical sales
Invest Like a
Medical Insider
You've spent your career inside medicine. Now invest in its future — with the same AI diligence infrastructure that institutional VCs use. The MedVC Syndicate gives physicians, dentists, and medical professionals exclusive access to pre-vetted deals.
What Our Members Say
"MedVC.ai found our Series A lead before we even started our roadshow. The Complizen regulatory report was the first thing the VC asked for — and we already had it."
"We deployed a custom Yutori Scout for our surgical robotics thesis. Within two weeks we had 14 qualified deals, each with a regulatory risk score. It replaced two months of analyst work."
"As a physician-investor, I never had access to this quality of deal flow. The Syndicate gives me institutional-grade diligence on every deal I consider."
Download the 2026
Medical Startup Diligence Checklist
27 questions VCs will ask about your FDA strategy. Most founders can't answer half of them. Can you?
No spam. Unsubscribe anytime. Trusted by 500+ medical founders.